Testing times: Detecting HIV in resource-limited settingsNovember 29, 2007Integrating HIV testing programmes into primary medical care can help achieve early diagnosis of HIV infection, even in relatively poor areas, research published in the online open access journal AIDS Research and Therapy has shown. Researchers from Harvard Medical School and the non-governmental organisation Partners In Health (PIH, www.pih.org), both based in Boston, USA set out to see if HIV diagnosis was delayed because doctors missed opportunities to test people who were at risk of HIV during clinic visits. The team works with the Haitian Ministry of Health to improve patients' access to primary care in central Haiti. This includes "provider-initiated HIV testing" (offering patients HIV tests when they visit primary care clinics) and the provision of free HIV treatment if required. The researchers then looked back at records from a single primary care clinic to examine the 'missed opportunities' and delays in diagnosing patients with HIV. The researchers found few missed opportunities for diagnosis in the clinic - 85% of the first 112 patients found to have HIV were diagnosed on their first visit to the doctor. Patients with HIV who were not diagnosed on their first visit had to wait a median of just 62 days until diagnosis. In the developing world, much HIV testing is done through maternity clinics or special HIV clinics that perform voluntary counselling and testing (i.e. on request of the individuals themselves) but that often do not provide other medical services or comprehensive HIV treatment. The authors suggest that provider-initiated testing at primary care clinics can be an effective way to identify patients with HIV infection. They write: "HIV prevention and treatment programs will not achieve success without addressing the urgent need for individuals to be aware of their HIV status in a timely manner and provider-initiated testing can be a successful strategy to address this concern." BioMed Central |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Indiana U. at APHA: Studies about why men and women use lubricants during sex An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||